How do I transition between different GLP-1 medications safely
Wegovy (semaglutide) and Mounjaro (tirzepatide) are examples approved in the UK for weight management
Sign up for discounts, special promotions, tips, and more
Avoid injecting into scarred, bruised, hard, or irritated skin
Analysts now predict that the GLP-1 market could reach $71 billion by 2032, driven by increasing demand for these medications in the treatment of obesity, type 2 diabetes, and cardiovascular conditions
Specific health conditions might prohibit the use of tirzepatide, including past instances of pancreatitis, medullary thyroid cancer, or considerable gastrointestinal issues